Prevention of recurrent herpes simplex, despite numerous recommended procedures, has
remained a problem. In one of our previous studies, inoculation with a nonspecific vaccine
gave results no better than those with the same vaccine which had been heatinactivated. It
appeared possible that a specific vaccine might produce greater benefit. A double-blind
study has recently been conducted in which one group of patients with recurrent herpes
simplex received a series of injections of a specific herpes virus vaccine while the control …